Interesting Article from MDLinx

MDLinx  Psychiatry 5 minutes to stay current Your Article Summary Acute and long-term treatment of late-life major depressive disorder: Duloxetine versus placebo The American Journal of Geriatric Psychiatry, 12/10/13 Other articles in Psychiatry >> Click here to see the complete list Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: A randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder International Clinical Psychopharmacology, 11/21/13 Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee Therapeutic Advances in Musculoskeletal Disease, 11/21/13 The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome Urology, 11/20/13 ©1999-2013 MDLinx, Inc.